Journal List > Korean Diabetes J > v.32(2) > 1002211

Lee, Ku, and Kim: Response: The Plasma Adiponectin Levels in Patients with Newly Diagnosed Type 2 Diabetes


2. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005. 26:439–451.
3. Abbasi F, Chang SA, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, Reaven GM, Reaven PD. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol. 2006. 290:R139–R144.
4. Martin M, Palaniappan LP, Kwan AC, Reaven GM, Reaven PD. Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care. 2008. 31:798–801.
6. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006. 29:1357–1362.
Similar articles